Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomesEmilia Bober, Ian Yeung, Edward Hindle et al.|Eye|2023Cited by 6
Predictive Factors for Magnetic Resonance Imaging Changes Suggestive of Demyelination in Adult Patients with Uveitis Scanned Prior to Commencing Adalimumab TherapyPriyanka Sanghi, Mark Westcott, Joshua Luis et al.|Ocular Immunology and Inflammation|2022Cited by 4